:strip_icc()/i.s3.glbimg.com/v1/AUTH_59edd422c0c84a879bd37670ae4f538a/internal_photos/bs/2020/b/P/NxAh5YQhuqBSKbnCrPlA/coronavac.jpg)
[ad_1]
The governor of Rio Grande do Norte, Fátima Bezerra (PT), is negotiating with the government of São Paulo the acquisition of doses of the Coronavac vaccine to immunize the population of Rio Grande do Norte. This information was confirmed by the governor G1. However, the number of doses to be purchased was not disclosed.
The vaccine is still in the third phase of testing, in which its effectiveness must be tested before being launched by the National Health Surveillance Agency (Anvisa).
Fátima participates in a meeting of the Governors’ Forum with the Ministry of Health, this Tuesday (8), and spoke with Governor João Dória about the subject – the meeting was in virtual format. The governor has not yet gone to São Paulo to meet with the president of the Butantan Institute, Dimas Covas. According to the government notice, at least 9 states have already shown interest in purchasing the vaccine.
After confirmation by the advisor, the governor herself commented on the matter through her social networks.
Although the RN does not have a plan for the production of any of the vaccines in the test phase, the government says it has been working to be at the forefront in logistics, to receive, distribute and apply vaccines against covid-19. The governors accuse the federal government of a national immunization plan against the coronavirus.
The Ministry of Health has not yet released the definitive vaccination plan against Covid-19. Last week, the Secretary of Health Surveillance of the Ministry of Health, Arnaldo Medeiros, said that the plan will only be ready when there is a vaccine registered in Anvisa.
The São Paulo government said on Monday (7) that the vaccination plan with CoronaVac begins on January 25, 2021. The first group to receive the coronavirus vaccine includes health professionals, indigenous people and quilombolas from all over. the state. 9 million people would be vaccinated in the first phase.
The SP government also announced that 4 million doses will be sold to other regions of the country.
Produced by the Chinese laboratory Sinovac in association with the Butantan Institute, the vaccine is still in the third phase of testing, in which effectiveness must be tested before being released by the National Sanitary Surveillance Agency (Anvisa). The São Paulo government’s forecast is that the documents on Coronavac will be delivered to Anvisa on December 15.
